GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30203% above fair value
$233.08−10.17 (-4.18%)
Close on Nov 18, 2026Market cap $13.80BP/E –Yield –
Glaukos net income
Net income is the profit left for shareholders after every expense, interest and tax.
Glaukos's net income for the twelve months ending Sep 30, 2026 was -$169.80M. For fiscal 2025 it was -$187.69M. The highest annual figure on record is $15.42M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$187.69M | – |
| FY2024 | Dec 31, 2024 | -$146.37M | – |
| FY2023 | Dec 31, 2023 | -$134.66M | – |
| FY2022 | Dec 31, 2022 | -$99.20M | – |
| FY2021 | Dec 31, 2021 | -$49.59M | – |
| FY2020 | Dec 31, 2020 | -$120.35M | -880.3% |
| FY2019 | Dec 31, 2019 | $15.42M | – |
| FY2018 | Dec 31, 2018 | -$12.95M | – |
| FY2017 | Dec 31, 2017 | -$92.00K | -102.0% |
| FY2016 | Dec 31, 2016 | $4.52M | – |
| FY2015 | Dec 31, 2015 | -$37.24M | – |
| FY2014 | Dec 31, 2014 | -$12.13M | – |
| FY2013 | Dec 31, 2013 | -$12.64M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.02M | – |
| Q2 FY2026 | Jun 30, 2026 | -$18.38M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.78M | – |
| Q4 FY2025 | Dec 31, 2025 | -$133.66M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.66M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$33.58M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$50.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$40.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$36.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$30.44M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.63M | -744.0% |
| Q4 FY2022 | Dec 31, 2022 | -$31.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$27.58M | -542.6% |
| Q2 FY2022 | Jun 30, 2022 | -$45.54M | – |
| Q1 FY2022 | Mar 31, 2022 | $5.38M | – |
| Q4 FY2021 | Dec 31, 2021 | -$21.87M | – |
| Q3 FY2021 | Sep 30, 2021 | $6.23M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.47M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.65M | -129.1% |
| Q3 FY2020 | Sep 30, 2020 | -$15.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$39.89M | – |
| Q1 FY2020 | Mar 31, 2020 | -$54.06M | – |
| Q4 FY2019 | Dec 31, 2019 | $36.58M | +1956.3% |
| Q3 FY2019 | Sep 30, 2019 | -$13.51M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.31M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.34M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.78M | +76.8% |
| Q3 FY2018 | Sep 30, 2018 | -$6.62M | -599.7% |
| Q2 FY2018 | Jun 30, 2018 | -$5.40M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.71M | -408.8% |
| Q4 FY2017 | Dec 31, 2017 | $1.01M | +650.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $878.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $134.00K | – |
See a number that looks wrong?